Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof

A porcine foot-and-mouth disease virus and recombinant antigen technology, applied in the field of biological vaccines, can solve the problems of unsatisfactory disease prevention and control, short duration, and uncommercialized products, and achieve good application prospects and high antibody levels

Active Publication Date: 2012-09-19
LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
View PDF1 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the large-scale animal experiments all ended in failure (the protection rate of the virus attack did not reach the national standard), mainly because the small molecule antigens developed could not stimulate the body to produce a protective level of neutralizing antibodies, and some even could produce a certain level of protection. Antibodies, but the duration is short, which cannot meet the needs of epidemic prevention and control
In addition, the developed viral particle-like capsid protein can induce the body to produce high-titer protective antibodies, and immunized animals can resist the challenge of homologous viruses, but the low yield and high cost of the antigen limit the application of the vaccine
Recently, people have increased the immunogenicity of vaccines by increasing T cell epitopes and foreign carrier proteins to enhance antigen presentation capabilities, increase molecular weight, and promote B cell maturation and differentiation, enhance immune response, and increase the level of peripheral blood circulating antibodies and duration, although the immunogenicity of the antigen has been improved to a certain extent, the anti-foreign carrier protein antibody produced after multiple immunizations has affected the immune effect of the target antigen; in addition, because the T cell epitope used by the researchers It is not a universal epitope, that is, it cannot be recognized by the major histocompatibility complex (MHC-I and II) of all host animals, so it cannot induce immune responses in all animals
In recent years, the epitope vaccine constructed by coupling the main immune factors such as IFN-γ, IL-2, etc. to the epitope small molecule has become a new breakthrough in the research of epitope vaccine, but the immune effect on this animal is not ideal
[0004] At present, although the porcine foot-and-mouth disease virus O-type recombinant vaccine developed by Professor Zheng Zhaoxin of Fudan University in Shanghai has applied for a patent and obtained the "Class I New Veterinary Drug Certificate" issued by the Ministry of Agriculture, the product has not been commercialized due to various reasons
In my country, inactivated vaccines are still used in the prevention of O-type foot-and-mouth disease in pigs. The UBI synthetic peptide vaccine has a poor immune effect and the market prospect is bleak. The inventor has previously applied for patents for sheep and cattle Asia 1 type multi-epitope vaccines, which are currently under review

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
  • Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
  • Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1 Preparation of Recombinant Antigen (EoIgG)

[0030] 1. Bioinformatics analysis of VP1 gene of type O foot-and-mouth disease virus:

[0031] The structural protein VP1 of foot-and-mouth disease virus is the dominant antigen of the virus. Both the isolated and purified natural VP1 protein or the recombinant expression product can induce the body to produce protective neutralizing antibodies with type specificity. The foot-and-mouth disease virus VP1 gene is composed of 639 nucleotides in full length, encoding a protein with 213 amino acids, and its main epitopes are concentrated in the 140-160th amino acid and 200-213th amino acid segment. The present invention uses DNAStar biological software to perform sequence analysis on three representative swine foot-and-mouth disease virus O type strains (O / China / 99, O / Miandian / 98, O / ZK / 93) isolated from my country, and determine the dominant epitope as The amino acid segment at positions 135-160, and the amino acid segment at...

Embodiment 2

[0039] Example 2 Preparation of different fragments of 3D protein of foot-and-mouth disease virus

[0040] 1. Bioinformatics analysis of 3D protein gene of foot-and-mouth disease virus:

[0041] Foot-and-mouth disease virus non-structural protein 3D is a viral RNA polymerase, which is highly conserved among the seven serotypes of foot-and-mouth disease virus. The protein can react with the virus-infected sera of the seven serotypes. The 3D gene has a total length of 1410 nucleotides, which encodes a protein with a length of 470 amino acids. The sequence analysis of 46 representative strains of seven serotypes obtained by DNAStar biological software and GenBank database comparison showed that the nucleotide homology The sex is higher than 90%, the amino acid homology is higher than 97%, and it is highly conservative. In this study, the 3D sequence of Asia1 FMD virus JS / China / 05 strain was used as the reference sequence to design primers to amplify the target gene fragment and expre...

Embodiment 3

[0044] Example 3. Vaccine preparation and immune efficacy experiment:

[0045] 1. Preparation of vaccine

[0046] The purified recombinant antigen prepared in Example 1 and the purified 3D protein full length prepared in Example 2 or its different fragments (3D1\3D2\3D3) were respectively quantified by Bio-Rad quantitative kit and then diluted into appropriate Concentration, the purified 3D protein fragments are configured with recombinant antigens in a ratio of 1:2 (V / V), and an equal volume of oil adjuvant ISA206 (France) is added to emulsify into vaccine preparations, and packed in 1ml / tube, which contains recombinant antigens 200μg, 3D protein full length or fragments 100μg.

[0047] 2. Immune efficacy test:

[0048] The prepared vaccine was used to inoculate pigs (200μg antigen + 100μg 3D protein full-length or fragments) by muscle route according to 1ml each. The results of immunization experiments showed that whether the recombinant antigen alone or combined with 3D protein im...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof and belongs to the field of biological vaccines. The pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen adopts a strategy of an antigenized antibody, after main antigen epitopes of a plurality of strains of pig foot-and-mouth disease virus O-type are connected in series reasonably, the plurality of strains of pig foot-and-mouth disease virus O-type are coupled with a pig intravenous gamma globulin (IgG) heavy chain constant region to construct the pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen, and after ration through a Bio-Rad protein ration kit, the pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and recombination foot-and-mouth disease virus 3D protein are matched to prepare the vaccines. Animal immunity testing results show that the vaccines can stimulate an organism to generate high-titer protective antibodies when the vaccines are used independently or matched with the recombination foot-and-mouth disease virus 3D protein to be used, an antibody level is higher than a national standard, and good application prospects are achieved.

Description

Technical field [0001] The invention relates to a porcine foot-and-mouth disease virus recombinant antigen and its application, in particular to a porcine foot-and-mouth disease virus O type broad-spectrum multi-epitope recombinant antigen and its application, and also relates to a vaccine prepared from the antigen, belonging to the field of biological vaccines. Background technique [0002] Foot-and-mouth disease, as a major animal disease that infects pigs, cattle and sheep, not only seriously threatens the healthy development of animal husbandry, but also involves the safety of animal-derived food and its export. Once an epidemic occurs, the losses will be heavy and the impact will be severe. Inactivated vaccines, as the main prevention and control substances, play a very important role in controlling the FMD epidemic. However, the production of such vaccines requires the construction of high-level biosafety production workshops to prevent the escape of pathogens, and it is ne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/62C12N15/63C12N1/15C12N1/19C12N1/21C12N5/10A61K39/135A61K48/00A61P31/14
Inventor 常惠芸邵军军丛国正林彤高闪电独军政
Owner LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products